biological science News
-
Profacgen Launched Antibiotic-free Expression System for Protein Expression Service
Profacgen, a state-of-the-art protein service provider located in the USA that provides custom protein services in biological sciences, recently launched a new and highly effective antibiotic-free expression system to meet scientists’ needs in the protein expression field. Expression vectors inserted with antibiotic resistance genes are mainstream recombinant expression systems that use ...
By Profacgen
-
Appointment boosts CSIRO bioinformatics research
“Bioinformatics, the interface between computing and biology, is a fast growing field and Dr Jermiin’s appointment is part of CSIRO’s move to build its skills base in genome bioinformatics,” CSIRO Entomology’s Chief, Dr Mark Lonsdale said. “Given Dr Jermiin’s experience and research excellence, we are excited about what he brings to our research in genome bioinformatics.” Dr Jermiin’s ...
-
nference Study Produces First Molecular Hypothesis Explaining COVID-19-Induced Myocarditis
nference, the AI-driven health technology company, today announced publication of a preprint study in bioRxiv that found the genetic alteration of some linear peptides expressed specifically in the human heart are mimicked by the SARS-CoV-2 polyprotein (replicase). The study has been submitted for peer-review. Authors of "Genetic alteration of human MYH6 is mimicked by SARS-CoV-2 polyprotein: ...
-
Tissium Appoints Sara Toyloy as Independent Board Member
TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has appointed Sara Toyloy as its fourth independent member of the Board of Directors. Ms. Toyloy has over 30 years of experience in the medical device industry. In 2020, she founded Fabrica Consulting LLC, a medical device consulting firm providing global ...
By TISSIUM
-
Profacgen Updated Its Membrane Protein Modeling Service Recently
Profacgen, a state-of-the-art protein service provider that provides custom protein services in the biological sciences, recently updated its membrane protein modeling service to better assist scientists in the field of structure-based protein engineering. Membrane proteins account for one third of all genes in the human genome, and they play critical roles as receptors, enzymes, ion channels, ...
By Profacgen
-
Notitia Biotechnologies company announces expansion of study population for Covid-19 phase 2 study (COVGUT20) for NBT-NM108
After months of preparation, Notitia Biotechnologies Company (Notitia) announced that its COVID-19 Phase 2 study (COVGUT20) for NBT-NM108 has been given support by the Food and Drug Administration (FDA) to expand its study population to all symptomatic COVID-19 patients. "Previously, our trial focused on COVID-19 patients with type 2 diabetes and prediabetes. Now with this timely expansion to ...
-
Rutgers researcher invents Microbiota Formula to help high-risk patients fight Covid-19
A Rutgers scientist has invented an early treatment for COVID-19 to prevent severe complications and hospitalizations in patients with prediabetes and diabetes by increasing beneficial bacteria in the gut and reducing organisms that cause coronavirus. The treatment – created by researcher Liping Zhao – was given the Investigational New Drug status by the Food and Drug ...
-
CD ComputaBio Introduces Four Docking Software for Drug Development
CD ComputaBio, a reliable computational service provider in the field of biology, is committed to assisting research and trials, as well as accessing the latest software, technologies, and expertise at a competitive price and fast turnaround for researchers. Molecular docking is a popular technique in drug design for predicting both binding patterns and binding affinity. CD ComputaBio has ...
-
BioVentrix Announces Raymond W. Cohen as Chairman of the Board and Newly Appointed Accredited Public Company Directors, Rinda K. Sama and Andrew G. Hinson to its Board of Directors
BioVentrix, Inc., a privately held medical device company focused on treating congestive heart failure via Transcatheter Ventricular Restoration (TCVR), today announced the appointment of Raymond W. Cohen as the Company’s chairman and named Rinda K. Sama and Andrew G. Hinson to its board of directors. Mr. Cohen has over 40 years’ experience leading and guiding a variety of private ...
-
USMI to Announce Successful Results of Phase I Clinical Trial Using Cold Atmospheric Plasma for the Treatment of Solid Tumors at the Baird 2021 Global Healthcare Conference
US Medical Innovations, LLC (USMI), a U.S. FDA-registered life-science and biomedical device company and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that Jerome Canady MD, CEO will be presenting at the Baird Global Healthcare Conference on Tuesday, September 14th from 10:15 to 10:45 AM ET. Dr. Canady will present results ...
-
Pacific Edge Appoints Dr Peter Meintjes As Its New CEO
Pacific Edge today announces the appointment of Dr Peter Meintjes, an experienced molecular diagnostics and genomics business leader, as its new Chief Executive Officer. Dr Meintjes, a New Zealand citizen currently resident in Boston, brings to Pacific Edge extensive global diagnostics, biotechnology, and commercial leadership expertise. He also has a track record for commercialising new and ...
-
Agilent Technologies and national university of singapore sign research collaboration agreement for lipidomics research
Agilent Technologies Inc. (NYSE: A) and the National University of Singapore (NUS) today announced an agreement to develop expertise and knowledge in the area of analytical lipidomics. The goal of the partnership is to develop workflow solutions that enable researchers to more accurately understand disease states. Under the terms of the agreement, Agilent's provision of sophisticated test and ...
-
Atomwise Adds Pharma Luminaries to Board of Directors and Scientific Advisory Board
Atomwise has strengthened its drug discovery and development expertise by expanding its Board of Directors and creating a Scientific Advisory Board (SAB). These appointments signal a critical milestone for Atomwise as the company focuses on its own internal pipeline. "This is the dream team," says Abraham Heifets, co-founder and CEO of Atomwise. "Mike Varney built Genentech's small molecule ...
-
USMI and JCRI Research Teams Develop Treatment System for COVID and other Respiratory Infections and Diseases
US Medical Innovations, LLC (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance in connection with JCRI-ABTS’s US National Stage Application (Serial No. 17/284,762) entitled “SYSTEM FOR TREATMENT OF RESPIRATORY INFECTIONS AND ...
-
Sirenas Establishes World Leading Scientific Advisory Board
Sirenas, LLC, a leader in the application of deep data mining approaches to the discovery of new classes of therapeutics from the global microbiome, today announced establishment of their world leading scientific advisory board. This board, with unparalleled expertise in the fields of drug discovery, molecular medicine and medicinal chemistry, includes: Benjamin Cravatt, Ph.D., professor and ...
By Sirenas
-
Jump in fall 2008 enrollments of first-time, full-time S&E graduate students
Enrollments of first-time, full-time graduate students in science and engineering (S&E) programs reached a record 108,819 in 2008, representing 20.6% of all graduate enrollments in these fields. The increase, 7.8% over fall 2007, was the largest 1-year increase in the last 10 years (table 1). For the first time since 2003, first-time enrollment in engineering fields grew faster among U.S. ...
-
JCRI Discovers the Mechanism using Canady Helios Cold Plasma to Induce Cell Death in Breast Cancer
The Jerome Canady Research Institute for Advanced Biological and Technological Sciences (JCRI-ABTS), in collaboration with US Medical Innovations, LLC (USMI), announced today that they have discovered the mechanism using Canady Helios™ Cold Plasma (CHCP) to induce cell death in breast cancer. Recently accepted for publication in the International Journal of Molecular Sciences, the article ...
-
JCRI-ABTS and USMI Successfully Complete Phase 1 Multi-Center Clinical Trial Using Canady Helios™ Cold Plasma for the Treatment of Cancer
The Jerome Canady Research Institute for Advanced Biological and Technological Sciences, LLC (JCRI-ABTS) and US Medical Innovations, LLC (USMI) announced today that they have successfully completed Phase 1 in their Clinical Trial using Canady Helios™ Cold Plasma (CHCP) for the treatment of recurrent and stage 4 solid tumors (IDE #G190195). The medical centers involved in the study were Rush ...
-
The Newly Developed Metabolomics Platform Brings New Insights into Enteroaggregative E. coli
With years of experience in metabolomics services, Creative Proteomics has developed a microbial metabolome analysis platform dedicated to providing high-quality, personalized microbial metabolomics services and reliable data support to clients worldwide. Microorganisms have existed on Earth for at least 3.8 billion years and are found in almost all corners of the biosphere. The diversity of ...
-
INOVIO to Report Fourth Quarter and Year-End 2021 Financial Results on March 1, 2022
INOVIO (NASDAQ: INO) announced today that fourth quarter 2021 financial results will be released after the market close on March 1, 2022. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update. A live and archived version of the audio presentation will be available online at ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you